pentobarbital will lessen the level or outcome of exemestane by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch. For clients receiving exemestane with a strong CYP3A4 inducer the proposed dose of exemestane is 50 mg daily following a food.pentobarbital and olopatadine intranasal each maximize sedation. Steer clear of or Use